Several possible studies
Story checked
Greenwood Genetic Center researcher wins major grant to explore cellular metabolism and glycosylation (opens in a new tab)
news-medical.net · 2026-10-21
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Greenwood Genetic Center researcher wins major grant to explore cellular metabolism and glycosylation
news-medical.net · 2026-10-21
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedHeather Flanagan-Steet, PhD, received a $1.4 million, five-year NIH Maximizing Investigators' Research Award (MIRA) R35 grant.View evidenceHide evidence
As stated$1.4 million, five-year
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 6Not checkedThe grant will support research into how metabolism and glycosylation work together during normal development and disease onset.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 6Not checkedFlanagan-Steet studies multiple metabolic disorders, including congenital disorders of glycosylation (CDG), a group of rare inherited diseases caused by changes in genes involved in glycosylation.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 6Not checkedHer team uses zebrafish models to study how changes in cellular metabolism and glycosylation contribute to disease, including PMM2-CDG, the most common form of CDG.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 5 of 6Not checkedThe researchers will investigate how changes in the building blocks needed for glycosylation affect cells and tissues, how those changes can disrupt development, and how they contribute to disease.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 6 of 6Not checkedBy studying several forms of CDG in the same model system, the team hopes to identify common biological pathways that contribute to disease and eventually point toward new ways to help patients and families.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
A conserved role for ALG10/ALG10B and the N -glycosylation pathway in the sleep-epilepsy axis.
medRxiv : the Preprint Server for Health Sciences · 2024 · PubMed
Congenital Disorders of Glycosylation
Oxford Medicine Online · 2017 · Crossref
Proteo-Metabolomic Profiling of PMM2-CDG Reveals Dysregulation of Retinoic Acid Synthesis, Myo-Inositol, and the Hexosamine Pathway.
2026 · Europe PMC
O-GlcNAcylation modulates expression and abundance of N-glycosylation machinery in an inherited glycosylation disorder.
Cell Reports · 2024 · PubMed, Europe PMC
Congenital Disorders of Glycosylation
Oxford Medicine Online · 2016 · Crossref